Christopher K Cote Selected Research

Adenosine Monophosphate (AMP)

2/2020

Combinations of early generation antibiotics and antimicrobial peptides are effective against a broad spectrum of bacterial biothreat agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher K Cote Research Topics

Disease

14	Infections 02/2021 - 02/2004
9	Plague (Bubonic Plague) 10/2021 - 10/2010
6	Melioidosis 01/2021 - 01/2018
5	Glanders 06/2021 - 01/2016
5	Tularemia 01/2021 - 01/2017
4	Anthrax 01/2021 - 10/2015
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2020
2	Bacteremia 01/2021 - 10/2010
1	Horse Diseases (Horse Disease) 01/2021
1	Meningitis 01/2021
1	Toxemia 01/2021
1	Infertility (Sterility) 01/2018
1	Yersinia Infections 06/2011

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 10/2021 - 07/2012
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 10/2010
6	Proteins (Proteins, Gene)FDA Link 01/2015 - 12/2010
5	AerosolsIBA 06/2021 - 06/2011
5	AntigensIBA 01/2020 - 02/2004
3	CytokinesIBA 01/2021 - 12/2010
2	anthrax toxin (anthrax lethal factor)IBA 01/2021 - 01/2020
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2021 - 01/2017
2	Monoclonal AntibodiesIBA 08/2020 - 10/2010
2	Attenuated VaccinesIBA 11/2019 - 07/2012
2	Virulence Factors (Pathogenicity Factors)IBA 01/2016 - 12/2011
1	Levofloxacin (Levaquin)FDA Link 01/2021
1	Amodiaquine (Camoquin)FDA Link 01/2021
1	ezrinIBA 01/2021
1	InflammasomesIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Plague VaccineIBA 01/2021
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2021
1	Recombinant Fusion ProteinsIBA 01/2021
1	SteamIBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 02/2020
1	Antimicrobial PeptidesIBA 02/2020
1	FluoroquinolonesIBA 01/2020
1	AminoglycosidesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	1,2-dehydrosalsolinolIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2017
1	AcidsIBA 01/2017
1	Immunoglobulin G (IgG)IBA 01/2016
1	Anthrax Vaccines (Vaccines, Anthrax)IBA 10/2015
1	CollagenIBA 01/2015
1	CalciumIBA 01/2014
1	Capsules (Microcapsules)IBA 01/2014
1	Adenosine Triphosphatases (ATPase)IBA 07/2012

Therapy/Procedure

6	Therapeutics 10/2021 - 01/2017
1	Duration of Therapy 01/2021